Palbociclib price in Pakistan (2026)
Bangladesh list prices converted into PKR, plus the registration rules of the DRAP, the legal import routes and the real cost build-up for Pakistan.
Quick answer: palbociclib price in Pakistan
Bangladeshi list price for generic palbociclib125 mg is BDT 400–BDT 400 per unit (about PKR 901.67–PKR 901.67), i.e. PKR 27,050–PKR 27,050 per 30-unit month; add freight, duty and distributor margin for $Pakistan.
FX basis: 1 USD = 122.87 BDT (September 2026). Conversions are indicative only — the binding price is your supplier quotation.
Currency conversion
| Item | BDT | PKR | USD |
|---|---|---|---|
| Lowest unit price | BDT 400 | PKR 901.67 | US$3.26 |
| Highest unit price | BDT 400 | PKR 901.67 | US$3.26 |
| 30-unit month (lowest) | BDT 12,000 | PKR 27,050 | US$97.66 |
| 30-unit month (highest) | BDT 12,000 | PKR 27,050 | US$97.66 |
Bangladesh benchmark (world reference price)
Registered brands and list prices for this molecule in Bangladesh (DGDA registration, via MedEx).
| Brand | Manufacturer | Strength | Unit price | ≈ USD | Pack |
|---|---|---|---|---|---|
| Cykin Lowest | Genvio Pharma Ltd. | 125 mg Capsule | BDT 400 | US$3.26 | 7 x 4: ৳ 11,200.00 |
| Palbo Lowest | Drug International Ltd. | 125 mg Capsule | BDT 400 | US$3.26 | 1 x 21: ৳ 8,400.00 |
| Palbocent Lowest | Incepta Pharmaceuticals Ltd. | 125 mg Capsule | BDT 400 | US$3.26 | 3 x 7: ৳ 8,400.00 |
| Palbokin Lowest | Ziska Pharmaceuticals Ltd. | 125 mg Capsule | BDT 400 | US$3.26 | 3 x 7: ৳ 8,400.00 |
| Palbolib Lowest | Aristopharma Ltd. | 125 mg Capsule | BDT 400 | US$3.26 | 3 x 7: ৳ 8,400.00 |
| Palboxen Lowest | Everest Pharmaceuticals Ltd. | 125 mg Capsule | BDT 400 | US$3.26 | 1 x 21: ৳ 8,400.00 |
| Palcigen Lowest | General Pharmaceuticals Ltd. | 125 mg Capsule | BDT 400 | US$3.26 | 1 x 21: ৳ 8,400.00 |
| Palker Lowest | Beacon Pharmaceuticals PLC | 125 mg Capsule | BDT 400 | US$3.26 | 1 x 21: ৳ 8,400.00 |
| Paltab Lowest | Renata PLC | 125 mg Tablet | BDT 400 | US$3.26 | 1 x 7: ৳ 2,800.00 |
Source: MedEx Bangladesh drug registry (list prices of DGDA-registered brands). Unit prices move with pack size, pharmacy and exchange rate — reference only. Original registry page
Import and regulatory notes
Drug Regulatory Authority of Pakistan (DRAP). Pakistan has a large domestic generic industry and DRAP-capped MRPs, which keeps locally produced generics cheap; oncology molecules are frequently sourced from Bangladesh or India instead of local production. Imported medicines need a DRAP import licence and a named-patient justification for unregistered products.
How to obtain it legally
- Obtain a prescription plus the diagnostic/genetic report from the treating physician (e.g. the target-mutation result).
- Confirm the exact brand and strength, and ask the supplier for the batch number, certificate of analysis (COA) and the manufacturer's GMP credentials.
- Clear the shipment through a DRAP-licensed importer or pharmacy; unregistered products go through the named-patient route.
- Check batch number, expiry and packaging on arrival, then follow the prescriber's monitoring schedule.
What adds to the price when you import
- International freight and cold chain (monoclonal antibodies and insulins need 2–8°C end-to-end).
- Customs duty and import VAT in Pakistan.
- Compliance, licensing and warehousing cost of the importer/distributor (typically 10–30%).
- Order size and pack configuration — full cases price below retail strips.
- Exchange-rate movement: this page converts at 1 USD = 122.87 BDT.
Frequently asked questions
How much does palbociclib cost in Pakistan?
There is no fixed public retail price for palbociclib in Pakistan in the sources we track (most supply is hospital- or named-patient based). Use the Bangladesh list price as the benchmark: BDT 400–BDT 400 (US$3.26–US$3.26) per unit, about PKR 901.67–PKR 901.67 in PKR per unit and PKR 27,050–PKR 27,050 per 30-unit month, before freight, customs duty and distributor margin.
Can I legally import palbociclib into Pakistan?
Yes, but only through the rules of the Drug Regulatory Authority of Pakistan (DRAP): Pakistan has a large domestic generic industry and DRAP-capped MRPs, which keeps locally produced generics cheap; oncology molecules are frequently sourced from Bangladesh or India instead of local production. Imported medicines need a DRAP import licence and a named-patient justification for unregistered products. Prescription medicines must move on a valid prescription through a licensed importer, pharmacy or hospital; personal-use imports need a named-patient / compassionate-use authorisation.
Are Bangladeshi or Indian generics of palbociclib approved in Pakistan?
We cannot confirm the registration status of every individual generic brand in Pakistan. Drug Regulatory Authority of Pakistan (DRAP) is the approving authority, and only products with a local product registration (or a special import authorisation) may be sold routinely. Ask your supplier for the local registration or import permit for the specific brand before you buy.
Why is the Bangladesh price a useful reference?
Bangladesh is a least-developed-country WTO member with a pharmaceutical patent exemption running to 2033, so local manufacturers can legally produce molecules that are still on patent elsewhere — and DGDA-registered list prices are public. That makes it the practical global floor price for on-patent targeted therapy and the benchmark used in import negotiations.
This molecule in other markets
This page is an information resource for healthcare professionals, licensed importers and patients under medical care. It is not medical advice, not a prescription service, and not an offer to sell prescription medicines to the public.
Also sourced for Pakistan
Need a verified quotation?
Send us the molecule, strength, pack size, quantity and destination country. We reply with a batch-traceable quotation, certificates of analysis and shipping documentation.
We supply licensed pharmacies, hospitals, importers and distributors — not direct-to-consumer patients.